Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine

Advanced Drug Delivery Reviews

Volumn 65, Issue 3, 2013, Pages 348-356

  Koppers Lalic, Danijela ^a   Hogenboom, Marye M ^a   Middeldorp, Jaap M ^a   Pegtel, D Michiel ^a  

^a University of Amsterdam   (Netherlands)

Author keywords

Exosomes; Gene therapy; Genetic transfer; MicroRNA; Virus

Indexed keywords

BIOMEDICAL RESEARCH; CLINICAL SETTINGS; COMMUNICATION PATHWAYS; ENDOSOMAL ESCAPES; EXOSOMES; GENETIC-TRANSFER; MICRORNAS; VIRUS-INFECTED CELLS;

CELLS; CYTOLOGY; GENE THERAPY; MEDICAL NANOTECHNOLOGY; RNA; VIRUSES;

COMPUTER VIRUSES;

CD81 ANTIGEN; ESCRT PROTEIN; MESSENGER RNA; MICRORNA; RNA POLYMERASE II; SMALL INTERFERING RNA; SNARE PROTEIN; VIRUS VECTOR;

BIOGENESIS; CELL COMMUNICATION; CONTROLLED STUDY; CYTOPLASM; DRUG DELIVERY SYSTEM; ENDOSOME; EXOSOME; GENE SILENCING; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIPID VESICLE; LYSOSOME; MASS SPECTROMETRY; MEMBRANE VESICLE; MULTIVESICULAR BODY; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RNA INTERFERENCE; ULTRACENTRIFUGATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ENTRY; VIRUS GENOME; VIRUS RELEASE;

ANIMALS; BIOLOGICAL TRANSPORT; EXOSOMES; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICRORNAS; NANOMEDICINE; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUSES;

EID: 84874981484     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.07.006     Document Type: Review

References (103)

1. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., de Gruijl T.D., Wurdinger T., Middeldorp J.M. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6328-6333.
2. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
3. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
4. Izquierdo-Useros N., Puertas M.C., Borras F.E., Blanco J., Martinez-Picado J. Exosomes and retroviruses: the chicken or the egg?. Cell. Microbiol. 2011, 13:10-17.
5. Pegtel D.M., van de Garde M.D., Middeldorp J.M. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim. Biophys. Acta 2011, 1809:715-721.
6. Katzmann D.J., Odorizzi G., Emr S.D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 2002, 3:893-905.
7. Williams R.L., Urbe S. The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell Biol. 2007, 8:355-368.
8. Hurley J.H. ESCRT complexes and the biogenesis of multivesicular bodies. Curr. Opin. Cell Biol. 2008, 20:4-11.
9. Simons M., Raposo G. Exosome-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009, 21:575-581.
10. Marsh M., van M.G. Cell biology. No ESCRTs for exosomes. Science 2008, 319:1191-1192.
11. Stuffers S., Sem W.C., Stenmark H., Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 2009, 10:925-937.
12. Fang Y., Wu N., Gan X., Yan W., Morrell J.C., Gould S.J. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 2007, 5:e158.
13. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., Schwille P., Brugger B., Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
14. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
15. Pelham H.R. SNAREs and the specificity of membrane fusion. Trends Cell Biol. 2001, 11:99-101.
16. Sollner T.H. Regulated exocytosis and SNARE function (Review). Mol. Membr. Biol. 2003, 20:209-220.
17. Johnstone R.M. Revisiting the road to the discovery of exosomes. Blood Cells Mol. Dis. 2005, 34:214-219.
18. Johnstone R.M. Exosomes biological significance: a concise review. Blood Cells Mol. Dis. 2006, 36:315-321.
19. Dumaswala U.J., Greenwalt T.J. Human erythrocytes shed exocytic vesicles in vivo. Transfusion 1984, 24:490-492.
20. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., Slot J.W., Geuze H.J., Stoorvogel W. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 2003, 278:10963-10972.
21. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
22. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
23. Lakhal S., Wood M.J. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 2011, 33:737-741.
24. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
25. Verweij F.J., van Eijndhoven M.A., Hopmans E.S., Vendrig T., Wurdinger T., Cahir-McFarland E., Kieff E., Geerts D., van der Kant R., Neefjes J., Middeldorp J.M., Pegtel D.M. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation. EMBO J. 2011, 30:2115-2129.
26. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 2010, 73:1907-1920.
27. Simpson R.J., Jensen S.S., Lim J.W. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099.
28. van Dommelen S.M., Vader P., Lakhal S., van Solinge W.W., Wood M.J., Schiffelers R.M. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 2011, 161:635-644.
29. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 1998, 273:20121-20127.
30. Keller S., Sanderson M.P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol. Lett. 2006, 107:102-108.
31. Stoorvogel W., Kleijmeer M.J., Geuze H.J., Raposo G. The biogenesis and functions of exosomes. Traffic 2002, 3:321-330.
32. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009, 10:513-525.
33. Zomer A., Vendrig T., Hopmans E.S., van E.M., Middeldorp J.M., Pegtel D.M. Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 2010, 3:447-450.
34. Gibbings D., Voinnet O. Control of RNA silencing and localization by endolysosomes. Trends Cell Biol. 2010, 20:491-501.
35. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
36. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol. 2005, 3:e85.
37. Jackson A.L., Linsley P.S. Noise amidst the silence: off-target effects of siRNAs?. Trends Genet. 2004, 20:521-524.
38. Sassen S., Miska E.A., Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008, 452:1-10.
39. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
40. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
41. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124:729-740.
42. Nemerow G.R., Stewart P.L. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 1999, 63:725-734.
43. Dimitrov D.S. Virus entry: molecular mechanisms and biomedical applications. Nat. Rev. Microbiol. 2004, 2:109-122.
44. Vallhov H., Gutzeit C., Johansson S.M., Nagy N., Paul M., Li Q., Friend S., George T.C., Klein E., Scheynius A., Gabrielsson S. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J. Immunol. 2011, 186:73-82.
45. Sieczkarski S.B., Whittaker G.R. Dissecting virus entry via endocytosis. J. Gen. Virol. 2002, 83:1535-1545.
46. Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137:433-444.
47. Kielian M., Rey F.A. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev. Microbiol. 2006, 4:67-76.
48. Kielian M. Class II virus membrane fusion proteins. Virology 2006, 344:38-47.
49. Cho Y.W., Kim J.D., Park K. Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol. 2003, 55:721-734.
50. Brown M.D., Schatzlein A.G., Uchegbu I.F. Gene delivery with synthetic (non viral) carriers. Int. J. Pharm. 2001, 229:1-21.
51. Zhang Y., Li H., Sun J., Gao J., Liu W., Li B., Guo Y., Chen J. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int. J. Pharm. 2010, 390:198-207.
52. Dass C.R., Choong P.F. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. J. Control. Release 2006, 113:155-163.
53. Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., Wilschut J. The virosome concept for influenza vaccines. Vaccine 2005, 23(Suppl. 1):S26-S38.
54. Seow Y., Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol. Ther. 2009, 17:767-777.
55. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol. 2003, 11:438-444.
56. Bundy B.C., Franciszkowicz M.J., Swartz J.R. Escherichia coli-based cell-free synthesis of virus-like particles. Biotechnol. Bioeng. 2008, 100:28-37.
57. Touze A., Bousarghin L., Ster C., Combita A.L., Roingeard P., Coursaget P. Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. J. Gen. Virol. 2001, 82:3005-3009.
58. Yamada T., Iwasaki Y., Tada H., Iwabuki H., Chuah M.K., VandenDriessche T., Fukuda H., Kondo A., Ueda M., Seno M., Tanizawa K., Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat. Biotechnol. 2003, 21:885-890.
59. Kaneda Y. HVJ liposomes and HVJ envelope vectors. Cold Spring Harb. Protoc. 2011, 2011:1281-1289.
60. Meckes D.G., Raab-Traub N. Microvesicles and viral infection. J. Virol. 2011, 85:12844-12854.
61. Benaroch P., Billard E., Gaudin R., Schindler M., Jouve M. HIV-1 assembly in macrophages. Retrovirology 2010, 7:29.
62. Pelchen-Matthews A., Raposo G., Marsh M. Endosomes, exosomes and Trojan viruses. Trends Microbiol. 2004, 12:310-316.
63. Gould S.J., Booth A.M., Hildreth J.E. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10592-10597.
64. Mack M., Kleinschmidt A., Bruhl H., Klier C., Nelson P.J., Cihak J., Plachy J., Stangassinger M., Erfle V., Schlondorff D. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 2000, 6:769-775.
65. daSilva L.L., Sougrat R., Burgos P.V., Janvier K., Mattera R., Bonifacino J.S. Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. J. Virol. 2009, 83:6578-6590.
66. Madrid R., Janvier K., Hitchin D., Day J., Coleman S., Noviello C., Bouchet J., Benmerah A., Guatelli J., Benichou S. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J. Biol. Chem. 2005, 280:5032-5044.
67. Campbell T.D., Khan M., Huang M.B., Bond V.C., Powell M.D. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn. Dis. 2008, 18:S2-S9.
68. Davis R.E., Ngo V.N., Lenz G., Tolar P., Young R.M., Romesser P.B., Kohlhammer H., Lamy L., Zhao H., Yang Y., Xu W., Shaffer A.L., Wright G., Xiao W., Powell J., Jiang J.K., Thomas C.J., Rosenwald A., Ott G., Muller-Hermelink H.K., Gascoyne R.D., Connors J.M., Johnson N.A., Rimsza L.M., Campo E., Jaffe E.S., Wilson W.H., Delabie J., Smeland E.B., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.C., Pierce S.K., Staudt L.M. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010, 463:88-92.
69. Middeldorp J.M., Pegtel D.M. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin. Cancer Biol. 2008, 18:388-396.
70. Sun D., Zhuang X., Xiang X., Liu Y., Zhang S., Liu C., Barnes S., Grizzle W., Miller D., Zhang H.G. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 2010, 18:1606-1614.
71. Bedi D., Musacchio T., Fagbohun O.A., Gillespie J.W., Deinnocentes P., Bird R.C., Bookbinder L., Torchilin V.P., Petrenko V.A. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomedicine 2011, 7:315-323.
72. Ruiss R., Jochum S., Mocikat R., Hammerschmidt W., Zeidler R. EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells-a new option for the treatment of B-CLL. PLoS One 2011, 6:e25294.
73. Temme S., Eis-Hubinger A.M., McLellan A.D., Koch N. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J. Immunol. 2010, 184:236-243.
74. Masciopinto F., Giovani C., Campagnoli S., Galli-Stampino L., Colombatto P., Brunetto M., Yen T.S., Houghton M., Pileri P., Abrignani S. Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 2004, 34:2834-2842.
75. Buseyne F., Le G.S., Boccaccio C., Abastado J.P., Lifson J.D., Arthur L.O., Riviere Y., Heard J.M., Schwartz O. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 2001, 7:344-349.
76. Temchura V.V., Tenbusch M., Nchinda G., Nabi G., Tippler B., Zelenyuk M., Wildner O., Uberla K., Kuate S. Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. Vaccine 2008, 26:3662-3672.
77. Kuate S., Cinatl J., Doerr H.W., Uberla K. Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology 2007, 362:26-37.
78. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 2007, 177:329-341.
79. Morita E., Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 2004, 20:395-425.
80. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., Sundquist W.I. The protein network of HIV budding. Cell 2003, 114:701-713.
81. Barreto A., Rodriguez L.S., Rojas O.L., Wolf M., Greenberg H.B., Franco M.A., Angel J. Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function. Viral Immunol. 2010, 23:595-608.
82. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435:108-114.
83. Flanagan J., Middeldorp J., Sculley T. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 2003, 84:1871-1879.
84. Dukers D.F., Meij P., Vervoort M.B., Vos W., Scheper R.J., Meijer C.J., Bloemena E., Middeldorp J.M. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 2000, 165:663-670.
85. Keryer-Bibens C., Pioche-Durieu C., Villemant C., Souquere S., Nishi N., Hirashima M., Middeldorp J., Busson P. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 2006, 6:283.
86. Dominska M., Dykxhoorn D.M. Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 2010, 123:1183-1189.
87. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
88. Shankar P., Manjunath N., Lieberman J. The prospect of silencing disease using RNA interference. JAMA 2005, 293:1367-1373.
89. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 2005, 11:50-55.
90. Dorn G., Patel S., Wotherspoon G., Hemmings-Mieszczak M., Barclay J., Natt F.J., Martin P., Bevan S., Fox A., Ganju P., Wishart W., Hall J. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 2004, 32:e49.
91. Friedrich I., Shir A., Klein S., Levitzki A. RNA molecules as anti-cancer agents. Semin. Cancer Biol. 2004, 14:223-230.
92. Liu Y.P., von Eije K.J., Schopman N.C., Westerink J.T., ter B.O., Haasnoot J., Berkhout B. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol. Ther. 2009, 17:1712-1723.
93. Qin X.F., An D.S., Chen I.S., Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:183-188.
94. Zidi I., Ben Amor N. Nanoparticles targeting HLA-G for gene therapy in cancer. Med. Oncol. 2012, 29:1384-1390.
95. Braasch D.A., Jensen S., Liu Y., Kaur K., Arar K., White M.A., Corey D.R. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 2003, 42:7967-7975.
96. Song E., Zhu P., Lee S.K., Chowdhury D., Kussman S., Dykxhoorn D.M., Feng Y., Palliser D., Weiner D.B., Shankar P., Marasco W.A., Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 2005, 23:709-717.
97. Waehler R., Russell S.J., Curiel D.T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8:573-587.
98. van den Boorn J.G., Schlee M., Coch C., Hartmann G. SiRNA delivery with exosome nanoparticles. Nat. Biotechnol. 2011, 29:325-326.
99. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5:487-495.
100. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29:341-345.
101. Balaj L., Lessard R., Dai L., Cho Y.J., Pomeroy S.L., Breakefield X.O., Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2011, 2:180.
102. Rana S., Zoller M. Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem. Soc. Trans. 2011, 39:559-562.
103. Borel F., van L.R., Koornneef A., Maczuga P., Ritsema T., Petry H., van Deventer S.J., Jansen P.L., Konstantinova P. In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs. J. RNAi Gene Silencing 2011, 7:434-442.